
News|Articles|November 5, 2025
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
Key Takeaways
- Bioproduction buffer preparation is shifting towards integrating advanced technologies for improved efficiency.
- Facilities are adopting a mix of traditional and innovative buffer strategies, such as in-line dilution.
A paradigm shift in bioproduction buffer preparation is on the horizon. While some facilities maintain made-in-house operations, some leverage a combination of different buffer strategies and technologies, like in-line dilution, to optimize their efficiency. A multi-criteria assessment framework is introduced here, allowing users to evaluate the mix of buffer strategies based on multiple criteria, which can be prioritized and weighted according to their organizational preferences.
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5


